Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy. [electronic resource]
Producer: 20170922Description: e0180995 p. digitalISSN:- 1932-6203
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- analysis
- C-Reactive Protein -- metabolism
- Carcinoma, Squamous Cell -- diagnosis
- Cetuximab -- therapeutic use
- Female
- Head and Neck Neoplasms -- diagnosis
- Humans
- Leukocyte Count
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- diagnosis
- Prognosis
- Research Design
- Retrospective Studies
- Squamous Cell Carcinoma of Head and Neck
- Survival Analysis
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.